{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T15:29:28Z","timestamp":1786116568682,"version":"build-2736575974"},"reference-count":50,"publisher":"BMJ","issue":"8","license":[{"start":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T00:00:00Z","timestamp":1785974400000},"content-version":"unspecified","delay-in-days":5,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"CAMS Innovation Fund for Medical Sciences","award":["2021-I2M-1-070"],"award-info":[{"award-number":["2021-I2M-1-070"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82273960"],"award-info":[{"award-number":["82273960"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82402133"],"award-info":[{"award-number":["82402133"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82404663"],"award-info":[{"award-number":["82404663"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82473956"],"award-info":[{"award-number":["82473956"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Immunother Cancer"],"accepted":{"date-parts":[[2026,6,3]]},"published-print":{"date-parts":[[2026,8]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Immune checkpoint blockade (ICB) therapy has emerged as a pivotal cancer treatment by activating antitumor immunity. However, its clinical efficacy remains limited in many patients, highlighting the need for combination strategies to overcome resistance. Inducing immunogenic cell death (ICD) represents a promising approach to remodel the immunosuppressive tumor microenvironment and improve ICB efficacy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      A high-throughput screen of a natural compound library identified potent ICD inducers. Polyphyllin II (PPII), a bioactive component from\n                      <jats:italic>Paris polyphylla<\/jats:italic>\n                      , was selected for further investigation. Its effects on ICD markers, tumor growth, and immune activation were evaluated in vitro and in vivo. Limited proteolysis-mass spectrometry was employed to identify the direct target of PPII, followed by mechanistic studies using molecular and immunological assays.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      PPII was identified as a potent ICD inducer, stimulating the release of high mobility group box 1, ATP, and calreticulin from tumor cells. PPII suppressed tumor growth and enhanced antitumor immunity by promoting dendritic cell maturation and antigen cross-presentation, leading to CD8\n                      <jats:sup>+<\/jats:sup>\n                      T-cell activation. Mechanistically, PPII directly bound to glucose-regulated protein 75 (GRP75), enhancing endoplasmic reticulum-mitochondrial tethering, provoking endoplasmic reticulum stress and mitochondrial calcium overload, and promoting cytochrome c release and caspase-3 activation. This cascade ultimately triggered gasdermin E (GSDME)-mediated pyroptosis. Furthermore, PPII synergized with anti-programmed cell death protein 1 therapy by reprogramming the tumor immune microenvironment and promoting systemic antitumor immunity.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Our findings identify GRP75 as a novel therapeutic target for cancer immunotherapy and highlight PPII-driven immune reprogramming as a translatable strategy to potentiate ICB efficacy through the induction of immunogenic pyroptosis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/jitc-2026-015043","type":"journal-article","created":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T11:25:26Z","timestamp":1786015526000},"page":"e015043","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Targeting GRP75 by natural compound polyphyllin II triggers mitochondrial calcium overload and pyroptosis to potentiate cancer immunotherapy"],"prefix":"10.1136","volume":"14","author":[{"given":"Yuting","family":"Wang","sequence":"first","affiliation":[{"name":"Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingwen","family":"Dong","sequence":"additional","affiliation":[{"name":"Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China"},{"name":"Academy of Military Medical Sciences, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Long","sequence":"additional","affiliation":[{"name":"Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liping","family":"Li","sequence":"additional","affiliation":[{"name":"Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cuicui","family":"Sun","sequence":"additional","affiliation":[{"name":"Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruoqi","family":"Li","sequence":"additional","affiliation":[{"name":"Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayu","family":"Zhang","sequence":"additional","affiliation":[{"name":"Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yichen","family":"Liu","sequence":"additional","affiliation":[{"name":"Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zipeng","family":"Yao","sequence":"additional","affiliation":[{"name":"College of Biomedical Engineering, Sichuan University, Chengdu, Sichuan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuqi","family":"Wang","sequence":"additional","affiliation":[{"name":"College of Biomedical Engineering, Sichuan University, Chengdu, Sichuan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Li","sequence":"additional","affiliation":[{"name":"Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingxiao","family":"Yin","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinbo","family":"Zhou","sequence":"additional","affiliation":[{"name":"Academy of Military Medical Sciences, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Zhang","sequence":"additional","affiliation":[{"name":"Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4398-8819","authenticated-orcid":false,"given":"Hongbin","family":"Deng","sequence":"additional","affiliation":[{"name":"Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,8,6]]},"reference":[{"key":"2026080604252009000_14.8.e015043.1","doi-asserted-by":"crossref","DOI":"10.1186\/s12943-025-02305-x","article-title":"Advances in cancer immunotherapy: historical perspectives, current developments, and future directions","volume":"24","author":"Zhang","year":"2025","journal-title":"Mol Cancer"},{"key":"2026080604252009000_14.8.e015043.2","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1038\/s41423-024-01207-0","article-title":"CAR-T and CAR-NK as cellular cancer immunotherapy for solid tumors","volume":"21","author":"Peng","year":"2024","journal-title":"Cell Mol Immunol"},{"key":"2026080604252009000_14.8.e015043.3","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2023.03.006"},{"key":"2026080604252009000_14.8.e015043.4","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2021.09.020"},{"key":"2026080604252009000_14.8.e015043.5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2023.02.016"},{"key":"2026080604252009000_14.8.e015043.6","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-022-01132-2"},{"key":"2026080604252009000_14.8.e015043.7","doi-asserted-by":"crossref","DOI":"10.1186\/s13045-020-00946-7","article-title":"Ferroptosis, necroptosis, and pyroptosis in anticancer immunity","volume":"13","author":"Tang","year":"2020","journal-title":"J Hematol Oncol"},{"key":"2026080604252009000_14.8.e015043.8","doi-asserted-by":"publisher","DOI":"10.1038\/s41580-025-00837-0"},{"key":"2026080604252009000_14.8.e015043.9","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/s41392-024-01958-2","article-title":"Pyroptosis in health and disease: mechanisms, regulation and clinical perspective","volume":"9","author":"Liu","year":"2024","journal-title":"Sig Transduct Target Ther"},{"key":"2026080604252009000_14.8.e015043.10","doi-asserted-by":"publisher","DOI":"10.1038\/nature22393"},{"key":"2026080604252009000_14.8.e015043.11","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.161","article-title":"Heat shock proteins: Biological functions, pathological roles, and therapeutic opportunities","volume":"3","author":"Hu","year":"2022","journal-title":"MedComm"},{"key":"2026080604252009000_14.8.e015043.12","doi-asserted-by":"publisher","DOI":"10.1038\/nrc3701"},{"key":"2026080604252009000_14.8.e015043.13","doi-asserted-by":"crossref","first-page":"101951","DOI":"10.1016\/j.arr.2023.101951","article-title":"Novel tumor therapy strategies targeting endoplasmic reticulum-mitochondria signal pathways","volume":"88","author":"Wu","year":"2023","journal-title":"Ageing Res Rev"},{"key":"2026080604252009000_14.8.e015043.14","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abq2424","article-title":"Mitochondria-ER contact mediated by MFN2-SERCA2 interaction supports CD8+ T cell metabolic fitness and function in tumors","volume":"8","author":"Yang","year":"2023","journal-title":"Sci Immunol"},{"key":"2026080604252009000_14.8.e015043.15","doi-asserted-by":"publisher","DOI":"10.1016\/j.tcb.2022.07.004"},{"key":"2026080604252009000_14.8.e015043.16","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202304203","article-title":"Targeting GRP75 with a Chlorpromazine Derivative Inhibits Endometrial Cancer Progression Through GRP75\u2013IP3R\u2010Ca 2+\u2010AMPK Axis","volume":"11","author":"Wang","year":"2024","journal-title":"Advanced Science"},{"key":"2026080604252009000_14.8.e015043.17","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/s41392-024-01950-w","article-title":"GRP75 triggers white adipose tissue browning to promote cancer-associated cachexia","volume":"9","author":"Chen","year":"2024","journal-title":"Sig Transduct Target Ther"},{"key":"2026080604252009000_14.8.e015043.18","doi-asserted-by":"publisher","DOI":"10.1038\/s41418-024-01414-2"},{"key":"2026080604252009000_14.8.e015043.19","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202206737","article-title":"Raddeanin A Enhances Mitochondrial DNA\u2010cGAS\/STING Axis\u2010Mediated Antitumor Immunity by Targeting Transactive Responsive DNA\u2010Binding Protein 43","volume":"10","author":"Yin","year":"2023","journal-title":"Advanced Science"},{"key":"2026080604252009000_14.8.e015043.20","doi-asserted-by":"crossref","first-page":"102695","DOI":"10.1016\/j.pbi.2025.102695","article-title":"Steroidal compounds in Paris polyphylla:structure, biological activities, and biosynthesis","volume":"84","author":"Hua","year":"2025","journal-title":"Curr Opin Plant Biol"},{"key":"2026080604252009000_14.8.e015043.21","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1080\/13880209.2022.2120021","article-title":"Polyphyllin II induced apoptosis of NSCLC cells by inhibiting autophagy through the mTOR pathway","volume":"60","author":"Jiao","year":"2022","journal-title":"Pharm Biol"},{"key":"2026080604252009000_14.8.e015043.22","doi-asserted-by":"crossref","DOI":"10.3390\/ijms231911890","article-title":"Polyphyllin II Induces Protective Autophagy and Apoptosis via Inhibiting PI3K\/AKT\/mTOR and STAT3 Signaling in Colorectal Cancer Cells","volume":"23","author":"Li","year":"2022","journal-title":"Int J Mol Sci"},{"key":"2026080604252009000_14.8.e015043.23","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2019.09.002"},{"key":"2026080604252009000_14.8.e015043.24","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2017.12.006"},{"key":"2026080604252009000_14.8.e015043.25","doi-asserted-by":"publisher","DOI":"10.1172\/JCI127471"},{"key":"2026080604252009000_14.8.e015043.26","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20050915"},{"key":"2026080604252009000_14.8.e015043.27","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.adc9584","article-title":"CCR7 acts as both a sensor and a sink for CCL19 to coordinate collective leukocyte migration","volume":"8","author":"Alanko","year":"2023","journal-title":"Sci Immunol"},{"key":"2026080604252009000_14.8.e015043.28","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0712394105"},{"key":"2026080604252009000_14.8.e015043.29","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1038\/s41422-023-00848-6","article-title":"Mannose antagonizes GSDME-mediated pyroptosis through AMPK activated by metabolite GlcNAc-6P","volume":"33","author":"Ai","year":"2023","journal-title":"Cell Res"},{"key":"2026080604252009000_14.8.e015043.30","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/s41401-024-01359-9","article-title":"The correlation between mitochondria-associated endoplasmic reticulum membranes (MAMs) and Ca2+ transport in the pathogenesis of diseases","volume":"46","author":"Zhao","year":"2025","journal-title":"Acta Pharmacol Sin"},{"key":"2026080604252009000_14.8.e015043.31","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00041.2020"},{"key":"2026080604252009000_14.8.e015043.32","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2022.102334","article-title":"Inhibition of nuclear deacetylase Sirtuin-1 induces mitochondrial acetylation and calcium overload leading to cell death","volume":"53","author":"Sun","year":"2022","journal-title":"Redox Biol"},{"key":"2026080604252009000_14.8.e015043.33","doi-asserted-by":"publisher","DOI":"10.1038\/sj.cdd.4401231"},{"key":"2026080604252009000_14.8.e015043.34","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1158\/2326-6066.CIR-22-0540","article-title":"Antigen-Loaded Extracellular Vesicles Induce Responsiveness to Anti-PD-1 and Anti-PD-L1 Treatment in a Checkpoint Refractory Melanoma Model","volume":"11","author":"Veerman","year":"2023","journal-title":"Cancer Immunol Res"},{"key":"2026080604252009000_14.8.e015043.35","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2079-1"},{"key":"2026080604252009000_14.8.e015043.36","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202317578","article-title":"Photo-Controlled Calcium Overload from Endogenous Sources for Tumor Therapy","volume":"63","author":"Hu","year":"2024","journal-title":"Angew Chem Int Ed Engl"},{"key":"2026080604252009000_14.8.e015043.37","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/s41392-025-02190-2","article-title":"Targeting tumor-intrinsic S100 calcium-binding protein A1 augments antitumor immunity and potentiates immunotherapy efficacy","volume":"10","author":"Guo","year":"2025","journal-title":"Sig Transduct Target Ther"},{"key":"2026080604252009000_14.8.e015043.38","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2024.03.019"},{"key":"2026080604252009000_14.8.e015043.39","doi-asserted-by":"publisher","DOI":"10.1038\/s41556-025-01668-z"},{"key":"2026080604252009000_14.8.e015043.40","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2025.03.014"},{"key":"2026080604252009000_14.8.e015043.41","doi-asserted-by":"crossref","first-page":"101342","DOI":"10.1016\/j.drup.2025.101342","article-title":"Hyperbaric oxygen targets RCN1 to modulate ER-mitochondria crosstalk and ameliorate sorafenib resistance in hepatocellular carcinoma","volume":"85","author":"Lin","year":"2026","journal-title":"Drug Resist Updat"},{"key":"2026080604252009000_14.8.e015043.42","doi-asserted-by":"crossref","first-page":"218204","DOI":"10.1016\/j.canlet.2025.218204","article-title":"High-fat diet induced ECM remodeling attenuates chemosensitivity in prostate cancer via activating Piezo1-dependent mitochondria-ER contacts","volume":"639","author":"Guan","year":"2026","journal-title":"Cancer Lett"},{"key":"2026080604252009000_14.8.e015043.43","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202300978","article-title":"Targeted Protein Upregulation of STING for Boosting the Efficacy of Immunotherapy","volume":"62","author":"Cho","year":"2023","journal-title":"Angew Chem Int Ed Engl"},{"key":"2026080604252009000_14.8.e015043.44","doi-asserted-by":"crossref","DOI":"10.1038\/s41392-025-02296-7","article-title":"Acevaltrate as a novel ferroptosis inducer with dual targets of PCBP1\/2 and GPX4 in colorectal cancer","volume":"10","author":"Yu","year":"2025","journal-title":"Signal Transduct Target Ther"},{"key":"2026080604252009000_14.8.e015043.45","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-23-1143"},{"key":"2026080604252009000_14.8.e015043.46","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-025-66667-y","article-title":"Efficacy, safety, and predictive biomarkers of neoadjuvant nab-paclitaxel and pembrolizumab in hormone receptor-positive breast cancer: A randomized pilot trial","volume":"16","author":"Waks","year":"2025","journal-title":"Nat Commun"},{"key":"2026080604252009000_14.8.e015043.47","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-024-01245-8"},{"key":"2026080604252009000_14.8.e015043.48","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2018.06.006"},{"key":"2026080604252009000_14.8.e015043.49","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2021.04.004"},{"key":"2026080604252009000_14.8.e015043.50","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2023.02.014"}],"container-title":["Journal for ImmunoTherapy of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jitc-2026-015043","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T11:25:29Z","timestamp":1786015529000},"score":1,"resource":{"primary":{"URL":"https:\/\/jitc.bmj.com\/lookup\/doi\/10.1136\/jitc-2026-015043"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":50,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,8,6]]},"published-print":{"date-parts":[[2026,8]]}},"alternative-id":["10.1136\/jitc-2026-015043"],"URL":"https:\/\/doi.org\/10.1136\/jitc-2026-015043","relation":{},"ISSN":["2051-1426"],"issn-type":[{"value":"2051-1426","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8]]}}}